tiprankstipranks
Evoke Pharma (EVOK)
NASDAQ:EVOK
US Market

Evoke Pharma (EVOK) Income Statement

Compare
466 Followers

Evoke Pharma Income Statement

Last quarter (Q3 2024), Evoke Pharma's total revenue was $2.65M, an increase of 69.83% from the same quarter last year. In Q3, Evoke Pharma's net income was $-1.31M. See Evoke Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 5.18M$ 2.51M$ 1.62M$ 23.02K$ 0.00
Gross Profit
$ 4.98M$ 2.14M$ 1.29M$ -63.69K$ 0.00
Operating Expenses
$ 12.41M$ 9.92M$ 9.44M$ 12.98M$ 7.15M
Depreciation and Amortization
$ 138.60K$ 7.79M$ 8.15M$ 13.05M$ 7.15M
EBITDA
$ -7.29M$ -7.72M$ -8.04M$ -13.04M$ 0.00
Operating Income
$ -7.43M$ -7.79M$ -8.15M$ -13.05M$ -7.15M
Other Income/Expenses
$ -361.40K$ -437.99K$ -386.31K$ -107.32K$ 28.80K
Pretax Income
$ -7.79M$ -8.22M$ -8.54M$ -13.15M$ -7.13M
Net Income
$ -7.79M$ -8.16M$ -9.03M$ -13.26M$ -7.10M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -27.97$ -31.16$ -40.40$ -74.91$ -45.84
Diluted EPS
$ -27.97$ -31.16$ -40.40$ -74.91$ -45.84
Weighted Average Shares Outstanding
278.59K 261.97K 223.51K 177.03K 154.83K
Weighted Average Shares Outstanding (Diluted)
278.59K 261.97K 223.51K 177.03K 154.83K
Currency in USD

Evoke Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis